Roy Proujansky - Net Worth and Insider Trading

Roy Proujansky Net Worth

The estimated net worth of Roy Proujansky is at least $0 dollars as of 2024-09-20. Roy Proujansky is the Director of 9 Meters Biopharma Inc and owns about 120 shares of 9 Meters Biopharma Inc (NMTRQ) stock worth over $0. Details can be seen in Roy Proujansky's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Roy Proujansky has not made any transactions after 2019-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Roy Proujansky

To

Roy Proujansky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Roy Proujansky owns 1 companies in total, including 9 Meters Biopharma Inc (NMTRQ) .

Click here to see the complete history of Roy Proujansky’s form 4 insider trades.

Insider Ownership Summary of Roy Proujansky

Ticker Comapny Transaction Date Type of Owner
NMTRQ 9 Meters Biopharma Inc 2019-05-24 director

Roy Proujansky Latest Holdings Summary

Roy Proujansky currently owns a total of 1 stock. Roy Proujansky owns 120 shares of 9 Meters Biopharma Inc (NMTRQ) as of May 24, 2019, with a value of $0.

Latest Holdings of Roy Proujansky

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NMTRQ 9 Meters Biopharma Inc 2019-05-24 120 0.00 0

Holding Weightings of Roy Proujansky


Roy Proujansky Form 4 Trading Tracker

According to the SEC Form 4 filings, Roy Proujansky has made a total of 0 transactions in 9 Meters Biopharma Inc (NMTRQ) over the past 5 years. The most-recent trade in 9 Meters Biopharma Inc is the acquisition of 50 shares on May 24, 2019, which cost Roy Proujansky around $1,280.

Insider Trading History of Roy Proujansky

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Roy Proujansky Trading Performance

GuruFocus tracks the stock performance after each of Roy Proujansky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roy Proujansky is -27.16%. GuruFocus also compares Roy Proujansky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roy Proujansky within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Roy Proujansky's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Roy Proujansky

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.81 LIMIT LIMIT LIMIT LIMIT LIMIT

Roy Proujansky Ownership Network

Ownership Network List of Roy Proujansky

No Data

Ownership Network Relation of Roy Proujansky

Insider Network Chart

Roy Proujansky Owned Company Details

What does 9 Meters Biopharma Inc do?

Who are the key executives at 9 Meters Biopharma Inc?

Roy Proujansky is the director of 9 Meters Biopharma Inc. Other key executives at 9 Meters Biopharma Inc include Chief Financial Officer Bethany Sensenig , director & Chief Executive Officer John Temperato , and Chief Financial Officer Edward J Sitar .

9 Meters Biopharma Inc (NMTRQ) Insider Trades Summary

Over the past 18 months, Roy Proujansky made no insider transaction in 9 Meters Biopharma Inc (NMTRQ). Other recent insider transactions involving 9 Meters Biopharma Inc (NMTRQ) include a net sale of 9,100 shares made by Bethany Sensenig ,

In summary, during the past 3 months, insiders sold 0 shares of 9 Meters Biopharma Inc (NMTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,100 shares of 9 Meters Biopharma Inc (NMTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,100 shares.

9 Meters Biopharma Inc (NMTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

9 Meters Biopharma Inc Insider Transactions

No Available Data

Roy Proujansky Mailing Address

Above is the net worth, insider trading, and ownership report for Roy Proujansky. You might contact Roy Proujansky via mailing address: 144 Pau Nel Drive, Landenberg Pa 19350.

Discussions on Roy Proujansky

No discussions yet.